2nd TRANSCAN-3 Joint Call 2022

Basic Information

Network TRANSCAN-3
Website https://transcan.eu/funding/calls/joint-call-jtc-2022-.kl
Aim of the joint call Novel translational approaches to tackle the challenges of hard-to-treat cancers from early diagnosis to therapy
Type of joint call Two Stages - Call with pre-proposals and full proposals submissions
Events
Launch date 23/05/2022
Deadline Pre-Proposal 18/07/2022 Submitted proposal: 70
Deadline Full-Proposal 15/12/2022 Submitted proposal: 40
Evaluation End Date 16/03/2023 Successful proposal: 0 Proposals funded: 0
Is call co-funded? No
Call follow up funding
  • There are mechanisms in place to monitor
Call reasons
  • Achieving critical mass
  • Sharing competences and associated work
  • Addressing global issues
  • Developing common administrative procedures
  • Access to expertise from different countries
  • Addressing specific scientific and technological issues
Research fields
  • Health
Type of research
  • Basic research
  • Applied Research
Target groups
  • Higher Education Institutions (HEIs)
  • Public Research Organisations (PROs)
  • Private and Semi-private Research and Technology Organisations (RTOs)
  • SME (Small and Medium Enterprises)
Participating networks n/a

Organisations Participating

Country Organisation
Austria Austrian Science Fund (FWF)
Belgium National Fund for Scientific Research (FNRS)
Belgium Research Foundation Flanders (FWO)
Estonia Estonian Science Foundation (ETAG)
France ARC French foundation for Cancer Research (ARC-France)
France National Cancer Institute (INCa)
Germany Federal Ministry of Education and Research (BMBF)
Hungary National Research, Development and Innovation Office (NKFIH)
Ireland Health Research Board (HRB)
Israel Ministry of Health (CSO-MOH)
Italy Alliance Against Cancer (ACC)
Italy Ministry of Health (MOH/MDS)
Italy REGIONAL FOUNDATION FOR BIOMEDICAL RESEARCH (FRRB)
Italy Tuscany Region (TOS)
Latvia Latvian Council of Science (LCS)
Luxembourg National Fund for Research (FNR)
Norway Norwegian Cancer Society (NCS)
Norway Research Council of Norway (RCN)
Poland National Centre for Research and Development (NCBiR)
Romania Executive Agency for Higher Education, Research, Development and Innovation Funding (UEFISCDI)
Slovakia Slovak Academy of Science (SAS/SAV)
Spain Institute of Health Carlos III (ISCIII)
Spain Spanish Association Against Cancer Scientific Foundation (AECC FC)
Taiwan National Science and Technology Council / Ministry of Science and Technology (NSTC / MoST Taiwan)

Funded Projects

Acronym Title Start End No. partners
ANGELA Early detection of esophageal squamous cell carcinoma with t... 01/04/2024 31/03/2027 5
BileCanMet Precision medicine in cholangiocarcinoma: accurate tools for... 01/04/2024 31/03/2027 5
CAR4PDAC Hijacking stroma antigens for CAR-T cell immunotherapy of PDAC 01/04/2024 31/03/2027 4
IdeaTMEHCC Identification of therapeutic targets using HCC DErived orga... 01/04/2024 31/03/2027 4
MATTO-GBM Multimodality Artificial intelligence open-source Tools for ... 01/04/2024 31/03/2027 4
NK-4-GBM Metabolically optimised NK cell therapies for Glioblastoma 01/04/2024 31/03/2027 5
PANC-P53 Innovative peptide- and RNA-based strategies to modulate p53... 01/04/2024 31/03/2027 3
PLASTIG Tackling tumor heterogeneity and PLASTIcity as resistance me... 01/04/2024 31/03/2027 4
PRECEDENCE Genotype matched therapies in intrahepatic cholangiocarcinom... 01/04/2024 31/03/2027 6
PaCaNano Development of a pancreatic cancer drug-nanocarrier system s... 01/04/2024 31/03/2027 5
ReachGLIO Reaching the heterogeneous vascular landscape of glioblastom... 01/04/2024 31/03/2027 7
SIMMBAP Systemic immunological determinants of tumor evolution and t... 01/04/2024 31/03/2027 4
T-Plex EAC T-Plex-Capture: Isolation of neoantigen-specific CD8+ T cell... 01/04/2024 31/03/2027 4
iCC-Strat Risk stratification and subtyping of intrahepatic cholangioc... 01/04/2024 31/03/2027 4